These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3919480)

  • 1. The vascular endothelial cell antigen system.
    Cerilli J; Brasile L; Galouzis T; Lempert N; Clarke J
    Transplantation; 1985 Mar; 39(3):286-9. PubMed ID: 3919480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of the monocyte crossmatch in recipients of living-related HLA identical kidney grafts.
    Cerilli J; Bay W; Brasile L
    Hum Immunol; 1983 May; 7(1):45-50. PubMed ID: 6343308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of antivascular endothelial cell antibody with hyperacute rejection: a case report.
    Brasile L; Rodman E; Shield CF; Clarke J; Cerilli J
    Surgery; 1986 May; 99(5):637-40. PubMed ID: 3518110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of antimonocyte antibody in kidney transplant recipients.
    Cerilli GJ; Brasile L; Galouzis T; DeFrancis ME
    Transplantation; 1981 Dec; 32(6):495-7. PubMed ID: 6461953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against donor antigens on endothelial cells and monocytes in eluates of rejected kidney allografts.
    Claas FH; Paul LC; van Es LA; van Rood JJ
    Tissue Antigens; 1980 Jan; 15(1):19-24. PubMed ID: 12735328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of a donor-specific vessel crossmatch in renal transplantation.
    Cerilli J; Clarke J; Doolin T; Cerilli G; Brasile L
    Transplantation; 1988 Sep; 46(3):359-62. PubMed ID: 3047924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Root cause analysis of limitations of virtual crossmatch for kidney allocation to highly-sensitized patients.
    Jani V; Ingulli E; Mekeel K; Morris GP
    Hum Immunol; 2017 Feb; 78(2):72-79. PubMed ID: 27864154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of the monocyte crossmatch in living-related transplantation.
    Leichter HE; Ettenger RB; Robertson L; Fine RN
    Child Nephrol Urol; 1990; 10(4):186-8. PubMed ID: 2088588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The good, the bad, and the ugly of luminex donor-specific crossmatch.
    Chowdhry M; Makroo RN; Thakur Y; Sharma V; Singh M; Kumar M
    HLA; 2018 Jun; 91(6):501-506. PubMed ID: 29457879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luminex Solid-Phase Crossmatch for De Novo Donor-Specific Antibodies in Living-Donor Related Transplants.
    Mehrotra S; Sharma RK; Mayya M; Gupta A; Prasad N; Kaul A; Bhadauria DS
    Exp Clin Transplant; 2017 Aug; 15(4):394-399. PubMed ID: 28447925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. The implications for graft survival.
    ten Hoor GM; Coopmans M; Allebes WA
    Transplantation; 1993 Aug; 56(2):298-304. PubMed ID: 7689256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
    Gloor JM; DeGoey S; Ploeger N; Gebel H; Bray R; Moore SB; Dean PG; Stegall MD
    Transplantation; 2004 Jul; 78(2):221-7. PubMed ID: 15280682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin class and specificity of antibodies causing positive T cell crossmatches. Relationship to renal transplant outcome.
    Chapman JR; Taylor CJ; Ting A; Morris PJ
    Transplantation; 1986 Dec; 42(6):608-13. PubMed ID: 3538548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human endothelial cell antigens: molecular independence from HLA and expression in blood monocytes.
    Moraes JR; Stastny P
    Transplant Proc; 1977 Mar; 9(1):605-7. PubMed ID: 325796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloantibodies against donor epidermis and early kidney transplant rejection.
    Moraes JR; Moraes ME; Luo YM; Stastny P
    Transplantation; 1991 Feb; 51(2):370-3. PubMed ID: 1994530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation.
    Chu E; Umetsu D; Rosen F; Geha RS
    J Clin Invest; 1983 Sep; 72(3):1124-9. PubMed ID: 6193142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-reactive cytokine profiles after HLA-identical living-related kidney transplantation.
    Gerrits JH; van de Wetering J; Drabbels JJ; Claas FH; Weimar W; van Besouw NM
    Nephrol Dial Transplant; 2008 Jun; 23(6):2016-23. PubMed ID: 18156655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assignment of C1q-binding HLA antibodies as unacceptable HLA antigens avoids positive CDC-crossmatches prior to transplantation of deceased donor organs.
    Juhl D; Marget M; Hallensleben M; Görg S; Ziemann M
    Transpl Immunol; 2017 Mar; 41():17-21. PubMed ID: 28088367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.